Approximately 40-50% of chronic hepatitis patients progress to liver cirrhosis caused by on going liver cell damage [4, 5] .
Hepatitis C Virus (HCV) is the major etiological agent of post-transfusion and sporadic non-A, non-B hepatitis worldwide [1] [2] [3] [4] . At least 50-60% of people infected with HCV develop chronic hepatitis due to persistent HCV infection [3] .
Approximately 40-50% of chronic hepatitis patients progress to liver cirrhosis caused by on going liver cell damage [4, 5] . 2 Histopathology, 3 Nephrology, 4 Surgery, and 5 The prevalence of HCV infection differs from country to country and several reports have identified Egypt as a country with a relatively high prevalence [6] [7] [8] [9] . Rural areas in Egypt have higher prevalence of HCV infection than the urban areas [10, 11] . In Saudi Arabia, the prevalence of HCV infection in a population of intravenous drug users in Jeddah, was 74.6%, in drug dependent patients who did not use the intravenous route was 10.5% and in healthy Saudi males was 1.7%
only [12] .
The importance of genetic factors for HCV infection arises from the observation of different courses of infection despite the same source of infection [13] . Crucial genetic factors influencing the immune reaction are the human leucocyte antigens (HLA) encoded by the major histocompatibility complex (MHC) [14, 15] . Associations between HLA determinants and susceptibility to HCV remain controversial; while some studies did not reveal any significant associations [16] [17] [18] [19] , others highlighted the relevance of the serologically determined HLA-DR5 antigen or the corresponding DNA determined HLA-DRB1 alleles in chronic hepatitis C [20, 21] . Some authors have found other antigens such as DRB*1 09 [22, 23] , HLA-DR13 [24] , DRB*104, DRB1*03 [25] or DRB1*1301, and DQA1*0103 associated with viral clearance of HCV infection [26] .
In view of the high prevalence of HCV infection among dialysis patients, it is vital to know their outcome following renal transplantation. It is well known that viral proliferation increases following transplantation [27] . Also, there is an increased risk of liver disease following transplantation although it does not seem to reduce patient survival [28, 29] .
The aim of the current study is to investigate a possible relationship between susceptibility to H C Virus infection and human leukocyte antigen alleles among Egyptian and Saudi populations and to assess the outcome of renal transplantation in HCV positive patients.
Materials and Methods
This study was conducted between July 1999 to 
Results

HLA Typing and HCV Prevalence
Egyptian Population: We analyzed data of HLA typing of 55 Egyptian patients positive for HCV and 55 negative for HCV (control group). In this analysis, we found increased frequencies of some HLA phenotypes and decreased frequencies of other but without statistical significance Also, in some HLA phenotypes, the results of both patients and control groups were the same (Table 1 and 2).
Saudi Population:
Comparing the phenotype frequencies of HLA class I (Table 3 ) and class II alleles (Table 4) The role of HLA system in predisposing to HCV infection is still unclear. Some studies did not reveal any significant association between HLA phenotypes and susceptibility to HCV infection [16] [17] [18] [19] and this agrees with our data presented in this study for the Egyptian population. The absence of a relationship between HLA typing and susceptibility to HCV infection, means that the Egyptian population, from the view of HLA phenotype, are all equally susceptible to HCV infection.
In contrast, other studies have revealed association between some HLA phenotypes and HCV infection [20, 21] and our study revealed that in the Saudi population, the frequency of HLA-A19 was higher in HCV positive patients compared to con- All comparisons are made between the patients and controls. NS= Non Significant S= Significant
All comparisons are made between the patients and controls. NS = Non Significant S=Significant plantation. This is similar to a few other reports [28, 29, 32] . However, there are other reports which mention lower graft and patient survival in HCV positive patients after renal transplantation [24, 32, 33] . The reported enhanced mortality was caused predominantly by sepsis and these studies had longer follow-up period.
Although our study indicates good outcome at short-term more studies with longer follow-up period are required to determine the outcome of HCV-positive patients after renal transplantations.
